This site is intended for healthcare professionals only
LoginRegister
CDSCO Panel Rejects Phase II Data for Reliances RelCoVax COVID-19 Booster Over Immunogenicity GapCDSCO Panel Rejects Phase II Data for Reliance's RelCoVax COVID-19 Booster Over Immunogenicity Gap
Novo Nordisk Told to Increase Indian Patient Enrollment for Ziltivekimab StudyNovo Nordisk Told to Increase Indian Patient Enrollment for Ziltivekimab Study
ED Pulls Up 5 Pharma Firms in Tramadol-Alprazolam Black Market ProbeED Pulls Up 5 Pharma Firms in Tramadol-Alprazolam Black Market Probe
Indian Pharma market sees 6.9% Growth in May: ReportIndian Pharma market sees 6.9% growth in May: Report
Morepen Labs incorporates wholly owned subsidiary in DubaiMorepen Labs incorporates wholly owned subsidiary in Dubai
Gilead Sciences HIV injectionGilead Sciences twice-yearly injection for HIV prevention bags USFDA okay
Marksans Pharma Oxybutynin hydrochloride 2.5mg/5ml Oral SolutionMarksans Pharma arm gets marketing authorization for Oxybutynin hydrochloride 2.5mg/5ml Oral...
Zydus gets 2 USFDA observations for Ahmedabad oncology injectable siteZydus gets 2 USFDA observations for Ahmedabad oncology injectable site
Phase 3 trial initiated for Ifinatamab DeruxtecanPhase 3 trial initiated for Ifinatamab Deruxtecan in Pretreated Metastatic Castration-Resistant...
Exemeds Sitagliptin FDC Hits Roadblock as CDSCO Panel Flags No Added Safety BenefitExemed's Sitagliptin FDC Hits Roadblock as CDSCO Panel Flags No Added Safety Benefit
Govt extends deadline for submitting applications under PLI SchemeDoP extends deadline for submitting applications under PLI Scheme for pharma sector
Fresenius Told to Submit Global Data for Calcium Chloride Infusion ApprovalFresenius Told to Submit Global Data for Calcium Chloride Infusion Approval
X